Abstract
This is a summary of the original article ‘Development and Validation of the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ)’. Individuals with insomnia are best positioned to assess the impact of insomnia on their quality of life. Patient reported outcomes (PROs) are self-reported health measures created to allow people to record their experience of their disease. Chronic insomnia has a major impact on daytime functioning for patients, and on their quality of life. This summary of research provides an overview of a previously published article detailing the development and evaluation of the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ), as a tool to allow people with insomnia to report their experience of the impact on their daytime functioning.
Avoid common mistakes on your manuscript.
Reference
Hudgens S, Phillips-Beyer A, Newton L, et al. Development and validation of the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ). Patient. 2021;14:249–68. https://doi.org/10.1007/s40271-020-00474-z.
Acknowledgements
The authors thank Daniel Buysse and the University of Pittsburgh (holders of copyright on IDSIQ) for academic insights and initial development and authorship of the Daytime Insomnia Symptom Scale (DISS).
Funding
The journal’s Rapid Service and Open Access fees were funded by Idorsia Pharmaceuticals Ltd. The original publication and all studies involved were funded by Idorsia Pharmaceuticals Ltd., and formerly (prior to June 2017) by Actelion Pharmaceuticals Ltd.
Medical Writing and Editorial Assistance
This Summary of Research Article was prepared by Adam Beech at AXON Communications, funded by Idorsia Pharmaceuticals Ltd. Medical Writing and Editorial Assistance services were funded by Idorsia Pharmaceuticals Ltd.
Author Contributions
All authors reviewed and approved the final document.
Prior Publication
This is a summary of a peer-reviewed article previously published in the journal The Patient. 2021 14:249–268. https://doi.org/10.1007/s40271-020-00474-z.
Questionnaire Availability
Permission for broader use of the IDSIQ must be obtained from Idorsia Pharmaceuticals Ltd.
Disclosures
Stacie Hudgens and Louise Newton are employees of Clinical Outcomes Solutions. Clinical Outcomes Solutions was funded by Actelion and Idorsia to conduct the observational study, psychometrics validation, and exit interviews. Andrea Phillips-Beyer is the director of Innovus Consulting Ltd., which provided consulting services for Idorsia Pharmaceuticals Ltd., and received payment for the work outlined in the manuscript. Dalma Seboek Kinter is an employee and shareholder of Idorsia Pharmaceuticals Ltd. Heike Benes is an employee of Somni Bene Institut fűr Medizinische Forschung und Schlafmedizin Schwerin GmbH and the University of Robock Medical Center, Germany, which received financial support for conducting the interventional study.
Compliance with Ethics Guidelines
All studies involved in the original publication, including qualitative interviews, were reviewed and approved by an institutional review board, independent ethics committee and all procedures were in accordance with the International Council for Harmonization Good Clinical Practice, the Declaration of Helsinki of 1964 and national laws and regulations.
This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
Data Availability
Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
About this article
Cite this article
Hudgens, S., Phillips-Beyer, A., Newton, L. et al. Summary of Research: Development and Validation of the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ). Adv Ther 40, 2573–2576 (2023). https://doi.org/10.1007/s12325-023-02489-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12325-023-02489-y